Popular Ice Cream Brand Recalled Across 23 States for This Dangerous Reason—Here's What to Know
There's nothing better than a sweet treat like ice cream on a hot summer day. It's cool and refreshing, sweet and creamy, and all around everything right in the world. You can enjoy it in your favorite flavors, whether you prefer more classic fare like cookies and cream or something a bit more out there like mustard or blueberry goat cheese with basil pesto swirl. Ice cream is quintessential summer, and despite the fact that we enjoy it year-round, it tastes so much better in the sunshine.
😋😋SIGN UP to get delicious recipes, handy kitchen hacks & more in our daily Pop Kitchen newsletter🍳🍔
As sweet and unassuming as ice cream can be, though, sometimes it isn't the safe, innocuous treat that we've come to know and love. Beyond the fact that it can be a sugar and cholesterol bomb, if it isn't made right, it can actually be dangerous. Ice cream can be a breeding ground for bacteria due to fluctuations in temperature during processing and improper cleaning of equipment, and you might not know until it's too late. Luckily, there are safeguards in place to catch any potential issues before our favorite summer treat makes it to our freezers—but that doesn't mean that accidents don't happen.Unfortunately, you might want to double-check your freezer to make sure you don't have one of the slew of items affected by a recent recall affecting ice cream bars sold in a whopping 23 states. According to recent filings by the FDA, over 100,000 ice cream bars produced by Rich's Ice Cream were recalled due to concerns over potential listeria contamination. The recall, which impacts lot number 24351 through lot 25156, was initiated on June 27, according to the FDA notice, and is classified as Class II with a total of 110,292 cases potentially affected.
The impacted products include Chocolate Crunch Cake Bars, Strawberry Shortcake Bars, Rich Bars, Crumbled Cookie Bars, Orange Cream Bars, Fudge Frenzy Bars, Cotton Candy Twirl Bars, Savagely Sour Blue Raspberry Bars, Savagely Sour Cherry Bars, and Cool Watermelon Bars. Additionally, the frozen treats were individually packaged in plastic bags and sold in master cases.
As if the list of items weren't exhaustive enough, the potentially contaminated products were sold in Alabama, Arizona, California, South Carolina, Florida, Georgia, Illinois, Iowa, Louisiana, Massachusetts, Missouri, Nebraska, Nevada, New Jersey, New York, Ohio, Oklahoma, Oregon, Pennsylvania, Tennessee, Texas, Virginia, and Wisconsin. They were also distributed and sold in Nassau, Bahamas. Talk about ruining your summer vacation.
So far, there don't appear to be any reported illnesses, but it's worth it to tread with caution if you think you might have purchased the affected products. To find out more information or contact Rich's Ice Cream Co., you can visit their website, and be sure to check back here for the latest food news.Popular Ice Cream Brand Recalled Across 23 States for This Dangerous Reason—Here's What to Know first appeared on Parade on Jul 22, 2025
This story was originally reported by Parade on Jul 22, 2025, where it first appeared.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a minute ago
- Yahoo
Dr. Adam J. Schell Opens Nebraska Spine + Pain Center Satellite Clinic at CHI Health St. Mary's in Nebraska City
OMAHA, Neb., July 31, 2025 /PRNewswire/ -- Nebraska Spine + Pain Center is pleased to announce that board-certified orthopedic spine surgeon Dr. Adam J. Schell opens a new satellite clinic on August 12th, 2025. The new clinic is located inside of CHI Health St. Mary's, located at 1301 Grundman Boulevard, Nebraska City, Nebraska 68410. Dr. Schell brings over a decade of expertise specializing in both surgical and nonsurgical treatment for spinal disorders including stenosis, scoliosis, pinched nerves, herniated disks, and spinal trauma. His care philosophy focuses on customized, evidence-based approaches designed to relieve pain and restore function. "I am honored to expand my practice into Nebraska City," said Dr. Schell. "This satellite clinic enables us to better serve patients in the region, offering comprehensive spine care closer to home." The clinic offers full-service spine care, including consultations, diagnostics, and treatment planning. Patients benefit from state-of-the-art onsite imaging (X-ray, CT, MRI) and personalized care plans delivered in partnership with local providers. About Nebraska Spine + Pain Center Nebraska Spine + Pain Center offers comprehensive, multidisciplinary care for pain in the neck and back throughout Nebraska and western Iowa. Nebraska Spine + Pain Center is the region's leading spine health network, delivering comprehensive care with a team of fellowship-trained physicians and specialists. For appointments or referrals:Contact Nebraska Spine + Pain Center at (402) 496‑0404 or request an appointment online at Media Contact:Zach PetersMarketing CoordinatorNebraska Spine + Pain CenterPhone: (402) 496-0404Email: zpeters@ View original content to download multimedia: SOURCE Nebraska Spine + Pain Center Sign in to access your portfolio
Yahoo
a minute ago
- Yahoo
1 dead, multiple people sickened in Legionnaires' disease cluster in New York City
One person has died and nearly two dozen others are sick in a Legionnaires' disease cluster in New York City, officials said. The New York City Department of Health said July 30 that it is investigating the cluster, which has left one dead and 22 others sick in Central Harlem. Legionnaires' disease is a severe pneumonia caused by a type of bacteria called Legionella, according to the CDC. The risk to most people is low, and the disease is not contagious, the agency said. Some people, including those older than 50, smokers or those with a weakened immune system, are at higher risk for the disease, according to NYC Health. NYC Health said it believes the source of the bacteria causing this cluster is a cooling tower in the area. Here's what to know. Where is NYC Legionnaires' cluster? The Legionnaires' disease cluster is in Central Harlem. According to NYC Health, the following zip codes are affected: 10027 10030 10035 10037 10039 People who live or work around these ZIP codes and develop flu-like symptoms should see a health care provider right away, the agency said. What caused NYC Legionnaires' cluster? Is water safe to drink? NYC Health said the likely source of the bacteria causing the Legionnaires' cluster is a cooling tower in the area. Cooling towers, which are water systems typically found on the top of buildings, spray mist that can contain the bacteria that causes Legionnaires' disease, the agency said. All of the cooling towers in the affected area are being tested for the bacteria, the health department said. The health department also said the cluster does not involve any building's plumbing system, meaning it is safe to drink water, bathe, shower, cook and use air conditioners. What is Legionnaires' disease? Legionnaires' disease is a type of pneumonia caused by consuming water or mist contaminated with Legionella bacteria, according to the CDC. Symptoms of the disease, which can take up to 14 days after exposure to show up, include: Cough Fever Headaches Muscle aches Shortness of breath The disease can be treated with antibiotics, and most healthy people who get infected usually get better, but complications are possible. About 1 in 10 people who get Legionnaires' disease die from it, according to the CDC. How to stay safe from Legionnaires' disease Legionnaires' disease is a waterborne illness, so the CDC recommends cleaning pipes and devices that use water to remove germs and debris. Prevention methods include flushing showerheads and faucets that haven't been used recently, and regularly cleaning devices that use water, per the CDC. Owners of cooling towers, decorative fountains and hot tubs should follow manufacturer instructions for cleaning, disinfecting and maintenance, the CDC said. Melina Khan is a national trending reporter for USA TODAY. She can be reached at This article originally appeared on USA TODAY: 1 dead in Legionnaires' disease cluster in NYC: Where, what to know Solve the daily Crossword
Yahoo
a minute ago
- Yahoo
LucyRx Announces the Acquisition of CerpassRx, Enhancing Clinical Excellence and Expanding Access to Innovative Healthcare Solutions
This strategic move brings together industry leading service with modern, member-first prescription care. BETHESDA, Md., July 31, 2025--(BUSINESS WIRE)--LucyRx, a fast-scaling, next-generation pharmacy benefits manager (PBM) known for simplifying and improving access to prescription care, has signed a definitive agreement to bring CerpassRx into the LucyRx organization. The combination brings together CerpassRx's proven track record of exceptional service and cost containment with LucyRx's technology-driven clinical approach, all under a shared vision for smarter, more transparent prescription care. CerpassRx is a division of Nomi Health, a direct healthcare company. The transaction is subject to regulatory approvals and customary closing conditions and is expected to close in Q3 2025. By combining LucyRx's technology-driven clinical model with CerpassRx's service-first approach and cost containment expertise, this partnership creates a more impactful PBM solution - one that delivers smarter care, stronger savings, and a seamless experience for clients and members alike. Distinct Strengths. Shared Mission. Greater Value. LucyRx and CerpassRx bring distinct but highly complementary capabilities to this new chapter. LucyRx offers a proprietary Formulary Marketplace, a broad Connected Specialty Care Network that integrates leading health systems and specialty pharmacies, and personalized clinical guidance through its Care Guide model. Its clinical programs focused on high-impact areas like GLP-1 therapies and Women's Health deliver smarter, more proactive prescription care for members. CerpassRx excels in driving down prescription costs through proprietary cost containment strategies, flexible formulary design, and tailored clinical programs. With a high-touch service model, it delivers rapid implementation and measurable outcomes, earning a reputation for disrupting the traditional PBM model and building long-term trust with clients and members. Together, they form a national PBM platform that is performance-driven, clinically forward, and relentlessly focused on serving clients and members with clarity and accountability. A More Impactful Platform for Clients and Members Smarter Cost Containment: CerpassRx's proven cost-saving programs layered onto LucyRx's transparent pricing and formulary marketplace. Stronger Member Support: Integrated clinical teams, anchored by LucyRx's Care Guides and CerpassRx's personalized service culture. Scalable Innovation: LucyRx's AI-powered insights and infrastructure amplify CerpassRx's high-touch service, making care more personal at scale. "CerpassRx is a strong cultural and strategic fit for LucyRx," said David Blair, CEO of LucyRx. "We're combining two organizations who are relentlessly focused on performance, innovation and compassion, and continually raising the bar for what clients and members can expect from a PBM." "We're proud of the foundation CerpassRx has built, and we believe LucyRx is the right partner to take it even further," said Mark Newman, CEO and Co-Founder of Nomi Health. "This agreement reflects a shared vision for more transparent, tech-forward pharmacy care and we're confident it will create long-term value for clients, members, and the broader market." "Clients expect more from their PBM, and they should," said Susan Thomas, Chief Commercial Officer at LucyRx. "Together with CerpassRx, we expand both the reach and depth of our solutions. And we'll deliver an experience that is more personal, more affordable and more clinically impactful." "Joining LucyRx is a natural next step for our clients and our team," said John Nicolosi, PharmD, Interim President of CerpassRx. "Our shared values of clarity, accountability, and care make this a powerful combination. We're excited to extend our impact with the support of LucyRx's technology, scale, and clinical approach." What Clients and Members Can Expect There will be no changes to service, support, or operations as a result of this agreement. Clients and members will continue to receive the same high-quality care and responsiveness they've come to expect from both organizations. This move builds on LucyRx's momentum as a PBM committed to doing things differently, with an emphasis on clarity, clinical rigor, and measurable outcomes. As part of this agreement, Nomi Health and LucyRx will continue working together to support their shared clients and build on current partnership efforts to reduce pharmacy costs for both employers and their members, advancing a shared commitment to bring more transparency, innovation, and affordability to healthcare. About LucyRx LucyRx is fast-scaling, independent, next-generation pharmacy benefit manager (PBM) redefining prescription care. Fueled by innovation and decades of leadership experience, LucyRx delivers better outcomes through its integrated specialty network, formulary marketplace, and next-day home delivery solutions. Powered by its proprietary AI platform, LucyIQ™, the company provides real-time insights that support evidence-based clinical decisions, clear pricing, and exceptional service from U.S.-based pharmacy technicians. Partnering with more than 60,000 pharmacies, LucyRx serves over 1,200 clients nationwide. This is prescription care, brilliantly reimagined. Learn more at About CerpassRx CerpassRx is a leading, full-service, pharmacy benefit manager based in Dallas-Fort Worth, Texas. Its services include prescription optimization, flexible formulary designs, personalized member support, and efficient mail and specialty pharmacy programs. Committed to driving efficiency and enhancing pharmacy benefit management, CerpassRx helps clients navigate the complexities of prescription care. For more information, visit About Nomi Health Nomi Health is rebuilding healthcare through its direct model. Founded in 2019, the company's integrated platform combines analytics, direct provider networks, and real-time payment solutions - providing the infrastructure that powers better healthcare. The company serves 4,000 customers nationwide, impacting 30 million lives and influencing over $200 billion in healthcare spend. Based in Orem, Utah, Nomi Health leads the movement to rebuild America's healthcare system. Learn more at View source version on Contacts Media Contact for LucyRx Tricia Bancroft516-241-6157press@ Strategic Partnerships Contact at LucyRx Alex Motola, Chief Business Officer and Head of M&Aamotola@ Media Contact for Nomi Health Rebeca Damico385-887-1641rebeca@ Sign in to access your portfolio
